Moleculin’s Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa

by in

Moleculin announced that it has entered into an agreement with The University of Iowa Pharmaceuticals for the development of a formulation for WP1732.